bunitrolol has been researched along with Carcinoma, Hepatocellular in 1 studies
bunitrolol: was heading 1975-94 (see under PROPANOLAMINES 1975-90); KO 1366 was see BUNITROLOL 1975-94; use PROPANOLAMINES to search BUNITROLOL 1975-94; a beta-adrenergic receptor antagonist with weak antiarrhythmic activity and minor ability to decrease the heart rate
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ono, S | 1 |
| Tsutsui, M | 1 |
| Gonzalez, FJ | 1 |
| Satoh, T | 1 |
| Masubuchi, Y | 1 |
| Horie, T | 1 |
| Suzuki, T | 1 |
| Narimatsu, S | 1 |
1 other study available for bunitrolol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Oxidative metabolism of bunitrolol by complementary DNA-expressed human cytochrome P450 isozymes in a human hepatoma cell line (Hep G2) using recombinant vaccinia virus.
Topics: Adrenergic beta-Antagonists; Carcinoma, Hepatocellular; Cytochrome P-450 Enzyme System; DNA, Complem | 1995 |